Format
Sort by
Items per page

Send to

Choose Destination

Best matches for maob schizophrenia:

Investigating association of four gene regions (GABRB3, MAOB, PAH, and SLC6A4) with five symptoms in schizophrenia. Sun J et al. Psychiatry Res. (2012)

Recent adaptive selection at MAOB and ancestral susceptibility to schizophrenia. Carrera N et al. Am J Med Genet B Neuropsychiatr Genet. (2009)

Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia. Zammit S et al. Am J Med Genet B Neuropsychiatr Genet. (2004)

Search results

Items: 19

1.

Downregulation of GNA13-ERK network in prefrontal cortex of schizophrenia brain identified by combined focused and targeted quantitative proteomics.

Hirayama-Kurogi M, Takizawa Y, Kunii Y, Matsumoto J, Wada A, Hino M, Akatsu H, Hashizume Y, Yamamoto S, Kondo T, Ito S, Tachikawa M, Niwa SI, Yabe H, Terasaki T, Setou M, Ohtsuki S.

J Proteomics. 2017 Mar 31;158:31-42. doi: 10.1016/j.jprot.2017.02.009. Epub 2017 Feb 16.

PMID:
28214564
2.

Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain.

Purves-Tyson TD, Owens SJ, Rothmond DA, Halliday GM, Double KL, Stevens J, McCrossin T, Shannon Weickert C.

Transl Psychiatry. 2017 Jan 17;7(1):e1003. doi: 10.1038/tp.2016.257.

3.

Monoamine oxidase and agitation in psychiatric patients.

Nikolac Perkovic M, Svob Strac D, Nedic Erjavec G, Uzun S, Podobnik J, Kozumplik O, Vlatkovic S, Pivac N.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Aug 1;69:131-46. doi: 10.1016/j.pnpbp.2016.02.002. Epub 2016 Feb 4.

PMID:
26851573
4.

Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach.

Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N, Belanger E, James A, George S, Weber H, Graham DL, Schweitzer R, Ladd TB, Learman R, Niculescu EM, Vanipenta NP, Khan FN, Mullen J, Shankar G, Cook S, Humbert C, Ballew A, Yard M, Gelbart T, Shekhar A, Schork NJ, Kurian SM, Sandusky GE, Salomon DR.

Mol Psychiatry. 2015 Nov;20(11):1266-85. doi: 10.1038/mp.2015.112. Epub 2015 Aug 18.

5.

Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis.

Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG.

Behav Brain Funct. 2014 Jul 29;10:26. doi: 10.1186/1744-9081-10-26.

6.

Psychosis-proneness correlates with expression levels of dopaminergic genes.

Grant P, Gabriel F, Kuepper Y, Wielpuetz C, Hennig J.

Eur Psychiatry. 2014 Jun;29(5):304-6. doi: 10.1016/j.eurpsy.2013.12.002. Epub 2014 Mar 14.

PMID:
24630741
7.

Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra.

Purves-Tyson TD, Handelsman DJ, Double KL, Owens SJ, Bustamante S, Weickert CS.

BMC Neurosci. 2012 Aug 6;13:95. doi: 10.1186/1471-2202-13-95.

8.

Investigating association of four gene regions (GABRB3, MAOB, PAH, and SLC6A4) with five symptoms in schizophrenia.

Sun J, Jayathilake K, Zhao Z, Meltzer HY.

Psychiatry Res. 2012 Jul 30;198(2):202-6. doi: 10.1016/j.psychres.2011.12.035. Epub 2012 Mar 12.

PMID:
22414661
9.

Monoamine oxidase a and B gene polymorphisms and negative and positive symptoms in schizophrenia.

Camarena B, Fresán A, Aguilar A, Escamilla R, Saracco R, Palacios J, Tovilla A, Nicolini H.

ISRN Psychiatry. 2012 Apr 19;2012:852949. doi: 10.5402/2012/852949. Print 2012.

10.

Association study of monoamine oxidase A/B genes and schizophrenia in Han Chinese.

Wei YL, Li CX, Li SB, Liu Y, Hu L.

Behav Brain Funct. 2011 Oct 6;7:42. doi: 10.1186/1744-9081-7-42.

11.

Associations of MAOA-VNTR or 5HTT-LPR alleles with attention-deficit hyperactivity disorder symptoms are moderated by platelet monoamine oxidase B activity.

Wargelius HL, Malmberg K, Larsson JO, Oreland L.

Psychiatr Genet. 2012 Feb;22(1):42-5. doi: 10.1097/YPG.0b013e328347c1ab.

PMID:
21610556
12.

Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia.

Kang SG, Park YM, Choi JE, Lim SW, Lee HJ, Lee SH, Kim YK, Kim SH, Cho SN, Kim L.

Hum Psychopharmacol. 2010 Jul;25(5):397-403. doi: 10.1002/hup.1130.

PMID:
20589923
13.

Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features.

Bergen SE, Fanous AH, Walsh D, O'Neill FA, Kendler KS.

Schizophr Res. 2009 Apr;109(1-3):94-7. doi: 10.1016/j.schres.2009.02.009. Epub 2009 Mar 5.

14.

Recent adaptive selection at MAOB and ancestral susceptibility to schizophrenia.

Carrera N, Sanjuán J, Moltó MD, Carracedo A, Costas J.

Am J Med Genet B Neuropsychiatr Genet. 2009 Apr 5;150B(3):369-74. doi: 10.1002/ajmg.b.30823.

PMID:
18553363
15.

Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.

Matsumoto C, Shinkai T, Hori H, Ohmori O, Nakamura J.

Psychiatry Res. 2004 Jun 30;127(1-2):1-7.

PMID:
15261699
16.

Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia.

Zammit S, Jones G, Jones SJ, Norton N, Sanders RD, Milham C, McCarthy GM, Jones LA, Cardno AG, Gray M, Murphy KC, O'Donovan MC, Owen MJ.

Am J Med Genet B Neuropsychiatr Genet. 2004 Jul 1;128B(1):19-20.

PMID:
15211623
17.

Sixth World Congress of Psychiatric Genetics X Chromosome Workshop.

Paterson AD.

Am J Med Genet. 1999 Jun 18;88(3):279-86.

PMID:
10374746
18.

A linkage study of schizophrenia to markers within Xp11 near the MAOB gene.

Dann J, DeLisi LE, Devoto M, Laval S, Nancarrow DJ, Shields G, Smith A, Loftus J, Peterson P, Vita A, Comazzi M, Invernizzi G, Levinson DF, Wildenauer D, Mowry BJ, Collier D, Powell J, Crowe RR, Andreasen NC, Silverman JM, Mohs RC, Murray RM, Walters MK, Lennon DP, Crow TJ, et al.

Psychiatry Res. 1997 May 30;70(3):131-43.

PMID:
9211575
19.

Blood monoamine oxidases and CT scans in subgroups of chronic schizophrenics.

Tachiki KH, Kurtz N, Kling AS, Hullett FJ.

J Psychiatr Res. 1984;18(3):233-43.

PMID:
6333507

Supplemental Content

Loading ...
Support Center